Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia

Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia

Methyldopa is the first-line drugs to treat hypertension in pregnancy. It can decrease blood pressure in preeclampsia by affecting a2-adrenoreceptors in central nervous system. However, it could also act by decreasing production of sFlt-1 antiangiogenic protein levels involved in the pathophysiolog...

Full description

Bibliographic Details
Main Authors:	Teri Wina Herwati, Yulistiani Yulistiani, Eddy Zarkaty M
Format:	Article
Language:	English
Published:	Universitas Airlangga 2018-04-01
Series:	Folia Medica Indonesiana
Subjects:	Methyldopa severe preeclampsia antiangiogenic soluble fms-like tyrosine kinase (sFlt-1)
Online Access:	https://e-journal.unair.ac.id/FMI/article/view/8052

Similar Items

High Level of Soluble FMS-Like Tyrosine Kinase-1 (sFlt-1) Serum in Pregnancy as a Risk Factor of Preeclampsia
by: I Gede Mega Putra, et al.
Published: (2016-07-01)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
by: Vivek Pant, et al.
Published: (2019-07-01)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
by: Colby A. Souders, et al.
Published: (2015-06-01)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

EFFECTS OF METHYLDOPA ON VEGF LEVELS AS PROANGIOGENIC FACTOR IN SEVERE PRE-ECLAMPSIA AT HAJI HOSPITAL, SURABAYA
by: Dina Ratna Juwita, et al.
Published: (2017-12-01)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
by: Lukas Penka, et al.
Published: (2020-04-01)

Correlation of urine sFlt-1/PLGF ratio with abnormal trophoblast invasion and apoptosis in pregnant women with preeclampsia
by: Xi-Ping Hong, et al.
Published: (2018-07-01)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
by: Lei Li, et al.
Published: (2020-02-01)

CORRELATION BETWEEN FMS-LIKE TYROSINE KINASE-1 (SFLT-1) CELL-FREE MESSENGER RNA EXPRESSION AND FMS-LIKE TYROSINE KINASE-1 (SFLT-1) PROTEIN LEVEL IN SEVERE PREECLAMPSIA AND NORMAL PREGNANCY
by: Jeffry Iman Gurnadi, et al.
Published: (2015-09-01)

Perbandingan Kadar Soluble Fms-Like Tyrosine Kinase 1 (SFLT1) Serum Kehamilan Normal dengan Preeklamsi Berat Serta Hubungannya dengan Tekanan Darah dan Derajat Proteinuria
by: Amillia Siddiq, et al.
Published: (2009-09-01)

Intraperitoneal Injection of High Tumor Necrosis Factor (TNF- α ) Serum Increase Soluble Fms-like Tyrosine Kinase 1 (sFlt-1) and Blood Pressure of Pregnant Mice
by: Bramantyo Aji Wicaksono, et al.
Published: (2015-05-01)

Activation of PAR-1/NADPH Oxidase/ROS Signaling Pathways is Crucial for the Thrombin-Induced sFlt-1 Production in Extravillous Trophoblasts: Possible Involvement in the Pathogenesis of Preeclampsia
by: Qi-tao Huang, et al.
Published: (2015-03-01)

Zusammenhang zwischen angiogenen Faktoren (sFlt-1/PlGF-Ratio) und klinischen Parametern des Schwangerschaftsausgangs bei manifesten hypertensiven Schwangerschaftserkrankungen
by: Tauscher, Anne
Published: (2013)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
by: Nesreen Nasser, et al.
Published: (2020-12-01)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
by: Szymon Kozłowski, et al.
Published: (2021-06-01)

MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
by: Lissette Carolina Sanchez-Aranguren, et al.
Published: (2020-07-01)

Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsmarker bei Schwangeren mit erhöhtem Präeklampsierisiko
by: Husse, Sorina
Published: (2017)

Apium graveolens Prevents Intrauterine Growth Restriction via Suppression of Antiangiogenic Factor Production
by: Exma Mu'tatal Hikmah, et al.
Published: (2018-08-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Prospektive Evaluierung von sFlt-1, PlGF und sEndoglin als prognostische Marker für die Entwicklung einer Präeklampsie bei Schwangerschaften mit uteriner Perfusionsstörung im 2. Trimenon
by: Schwarz, Friederike
Published: (2013)

Correlation of STAT4 and STAT6 expression levels in preeclampsia placenta with sFlt-1 and ADMA generation as well as placental hypoxia
by: Dong-Mei Su
Published: (2016-09-01)

Potential use of sFlt-1 and pterin to predict the clinical outcome of cardiovascular disease.
by: Marks, Edward Charles Arthur
Published: (2015)

Decision Threshold for Kryptor sFlt‐1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting
by: Lise Lotte Torvin Andersen, et al.
Published: (2021-09-01)

Soluble fms‐like tyrosine kinase‐1‐enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration
by: Dexun Hao, et al.
Published: (2019-10-01)

Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration
by: Ignacio Herraiz, et al.
Published: (2015-08-01)

Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsmarker bei Schwangeren mit erhöhtem Präeklampsierisiko
by: Husse, Sorina Ines
Published: (2015)

Pro-angiogenic therapeutics for preeclampsia
by: Adrian C. Eddy, et al.
Published: (2018-08-01)

MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment
by: Homira Rezai, et al.
Published: (2021-01-01)

Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
by: Karoline Mayer-Pickel, et al.
Published: (2019-09-01)

The umbilical cord, preeclampsia and the VEGF family
by: Olaya-C M, et al.
Published: (2018-11-01)

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells
by: Tadashi Sasagawa, et al.
Published: (2020-02-01)

Study on sEng, VEGF, PLGF, and sFlt-1 levels, and umbilical artery blood flow change in the pregnant women with preeclampsia
by: Xia Liu
Published: (2016-04-01)

Hubungan antara Soluble Fms-Like Tyrosine Kinase-1 (sFlt-1) pada Ibu Preeklampsia Berat dengan fetal outcome
by: Mona Dewi Utari, et al.
Published: (2020-02-01)

sFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF/GRP78/MMP2&9 axis
by: Sepideh Taghizadeh, et al.
Published: (2021-05-01)

Human sFLT1 Leads to Severe Changes in Placental Differentiation and Vascularization in a Transgenic hsFLT1/rtTA FGR Mouse Model
by: Rebekka Vogtmann, et al.
Published: (2019-03-01)

Maternal serum concentrations of angiogenic and antiangiogenic factors in threatened miscarriage at 7–12 weeks’ gestation and the risk of adverse pregnancy outcomes
by: Dina Gamal Eldeen Y. Elkholi, et al.
Published: (2013-09-01)

Methyldopa as an inductor of postpartum depression and maternal blues: A review
by: Michał Wiciński, et al.
Published: (2020-07-01)

Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia
by: Rahana Abd Rahman, et al.
Published: (2020-04-01)

FLT3-ITD Incidence and FLT-D835 Mutations in Acute Myeloid Leukemia Patients with Normal Karyotype in Morocco: A Preliminary Study
by: Hind Dehbi, et al.
Published: (2013-01-01)

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
by: Evelyn A. Huhn, et al.
Published: (2018-11-01)